Abstract #1003971: Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study

Documenti analoghi

• Clinical Effectiveness and Safety of Gliclazide MR and Linagliptin Combination in the Management of Patients With T2DM and Chronic Kidney Disease (CKD) Switched From Glimepiride - a Real-World, Retrospective, Observational Study
  di: Bhattacharyya, Supratik, et al.
  Pubblicazione: (2021)
• A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting
  di: Sanyal, Debmalya, et al.
  Pubblicazione: (2013)
• SUN-LB112 Efficacy & Safety After Switchover to Remogliflozin in Indian T2DM Patients - a Real World Study
  di: Bhattacharyya, Supratik, et al.
  Pubblicazione: (2020)
• Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients
  di: Hardy-Werbin, Max, et al.
  Pubblicazione: (2019)
• Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study
  di: Pérez-Belmonte, Luis M., et al.
  Pubblicazione: (2019)